Strong Financial Performance
Net sales increased 13% year-over-year to $120.9 million, and pro forma adjusted EBITDA increased 30% to $47.7 million with an EBITDA margin of 39.5%. Gross margins improved to 59% from 51.7% in the prior year.
Acquisition of Husky Technologies
CompoSecure announced a strategic combination with Husky Technologies, a global leader in injection molding equipment, expected to be highly accretive to CompoSecure's investors and offering significant long-term growth potential.
Raised Financial Guidance
Raised 2025 full-year guidance with non-GAAP net sales expected to be approximately $463 million and pro forma adjusted EBITDA between $165 million and $170 million. Issued strong guidance for 2026 with net sales of approximately $510 million and EBITDA of approximately $190 million.
Significant Cash Flow and Debt Reduction
CompoSecure had $224.6 million of cash and cash equivalents and reduced total debt from $330 million to $190 million, driven by strong free cash flow and proceeds from warrant exercises.